Table 2:
OR | 95% confidence interval |
P-value | ||
---|---|---|---|---|
Lower | Upper | |||
Sex | ||||
Male | REF | 0.001 | ||
Female | 1.21 | 1.06 | 1.37 | |
Age (years) | ||||
20–59 | REF | 0.016 | ||
60–69 | 0.87 | 0.74 | 1.03 | |
70–79 | 0.83 | 0.69 | 0.99 | |
>80 | 0.62 | 0.01 | 0.85 | |
ASA score | ||||
I–II | REF | 0.026 | ||
III–IV | 0.86 | 0.73 | 0.99 | |
Cardiac comorbidity | ||||
No | REF | 0.090 | ||
Yes | 0.88 | 0.76 | 1.02 | |
Pulmonary comorbidity | ||||
No | REF | 0.001 | ||
Yes | 0.75 | 0.65 | 0.86 | |
Diabetes mellitus | ||||
No | REF | |||
Yes | 1.03 | 0.89 | 1.25 | 0.74 |
DLCO | ||||
>40% | REF | 0.060 | ||
≤40% | 0.56 | 0.32 | 1.02 | |
Missing | 0.89 | 0.75 | 1.05 | |
FEV1 | ||||
>40% | REF | 0.039 | ||
≤40% | 0.69 | 0.32 | 1.49 | |
Missing | 1.19 | 1.02 | 1.37 | |
Previous thoracic surgery | ||||
No | REF | 0.43 | ||
Yes | 1.20 | 0.76 | 1.90 | |
Clinical stage | ||||
IA | REF | 0.78 | ||
IB | 1.01 | 0.89 | 1.19 | |
IIA | 1.06 | 0.87 | 1.27 | |
IIB | 1.13 | 0.88 | 1.38 | |
IIIA | 1.06 | 0.82 | 1.35 |
ASA: American Society of Anesthesiologists; DLCO: Diffusing capacity for carbon monoxide; FEV1: forced expiratory volume in 1 s; OR: odds ratio.